Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5283739
Max Phase: Preclinical
Molecular Formula: C20H19N5S
Molecular Weight: 361.47
Associated Items:
ID: ALA5283739
Max Phase: Preclinical
Molecular Formula: C20H19N5S
Molecular Weight: 361.47
Associated Items:
Canonical SMILES: C=CCn1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1
Standard InChI: InChI=1S/C20H19N5S/c1-2-12-25-19(15-7-10-21-11-8-15)23-24-20(25)26-13-9-16-14-22-18-6-4-3-5-17(16)18/h2-8,10-11,14,22H,1,9,12-13H2
Standard InChI Key: VEYFXSBWCZDGHP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 361.47 | Molecular Weight (Monoisotopic): 361.1361 | AlogP: 4.34 | #Rotatable Bonds: 7 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.85 | CX LogP: 3.98 | CX LogD: 3.98 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.39 | Np Likeness Score: -1.73 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):